Power Law company profile

Celltrion

Biotech & Life Sciences · Incheon, South Korea · Founded 2002 · IPO 2005 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$39B

Market cap · Apr/2026

Revenue

$3.45B

Latest reported FY

Investors

2 investors on Celltrion's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

VaxGen

KT&G Corporation

Global footprint

Where Celltrion has talent and traffic

Web traffic by country

120K monthly visits
across markets

🏳️ Korea83.3%

🏳️ Republic of5.4%

🇮🇳 India3.4%

🇺🇸 United States1.7%

🇨🇦 Canada1.6%

Top 5 markets shown

Patent intelligence

$101M patent portfolio · 149 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$101M

0.26% of market cap · 2.3× smaller than top peer Galapagos ($230M)

149 active patent families

Where Celltrion innovates Pharmaceutical drugDrugMedicinal chemistryChemical formulaPharmaceutical Substances

Above peer median on Strategic · Below peer median on Market

Quality vs same-sector peers

Celltrion on the five Patsnap quality dimensions

Celltrion in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Celltrion concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Celltrion and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Celltrion on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo